Top 5 Warren Buffett Stocks For 2019

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-688022858&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/688022858/960×0.jpg?fit=scale&q; data-height=&q;642&q; data-width=&q;960&q;&g; Portrait of male CEO in big corner office, looking out of window, at sunset. Photo Credit: Getty Royalty Free

&l;/p&g;&l;blockquote&g;&l;em&g;&a;ldquo;The heads of many companies are not skilled in capital allocation. Their inadequacy is not surprising because most bosses rise to the top because they have excelled in an area such as marketing, production, engineering, administration or, sometimes, institutional politics.&a;rdquo;&l;/em&g;&l;/blockquote&g;

-Warren Buffett, &l;a href=&q;http://www.berkshirehathaway.com/letters/1987.html&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;1987 letter to Berkshire Hathaway shareholders&l;/a&g;

The Oracle of Omaha observed the lack of emphasis on capital allocation over 30 years ago, and since then, it seems that little changed. A 2015 Harvard Business Review article entitled &a;ldquo;&l;a href=&q;https://hbr.org/2015/04/ceos-dont-care-enough-about-capital-allocation&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;CEO&a;rsquo;s Don&a;rsquo;t Care Enough About Capital Allocation&l;/a&g;&a;rdquo; found that hardly any top CEO&a;rsquo;s talked about return on invested capital (&l;a href=&q;https://www.newconstructs.com/education-return-on-invested-capital/&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;ROIC&l;/a&g;).

Top 5 Warren Buffett Stocks For 2019: Plexus Corp.(PLXS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Plexus Corp. (NASDAQ:PLXS) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $60.75.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Plexus (PLXS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Plexus Corp. (NASDAQ:PLXS) CAO Angelo Michael Ninivaggi, Jr. sold 6,250 shares of Plexus stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $61.79, for a total value of $386,187.50. Following the completion of the transaction, the chief accounting officer now owns 28,402 shares of the company’s stock, valued at $1,754,959.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Top 5 Warren Buffett Stocks For 2019: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By Jim Crumly]

    Biotech shares jumped following news of some big deals, with the SPDR S&P Biotech ETF (NYSEMKT:XBI) soaring 4.4%. Gold stocks slumped; the VanEck Vectors Gold Miners ETF (NYSEMKT:GDX) fell 1.3%. 

  • [By Shane Hupp]

    Boyer & Corporon Wealth Management LLC decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 64,434 shares of the exchange traded fund’s stock after selling 6,901 shares during the quarter. SPDR S&P Biotech ETF accounts for about 2.7% of Boyer & Corporon Wealth Management LLC’s investment portfolio, making the stock its 5th largest position. Boyer & Corporon Wealth Management LLC owned approximately 0.11% of SPDR S&P Biotech ETF worth $6,133,000 as of its most recent filing with the SEC.

  • [By Jim Crumly]

    Biotech stocks made gains today, with the SPDR S&P Biotech ETF (NYSEMKT:XBI) rising 1.3%. Consumer stocks were the laggards; the Consumer Staples Select Sector SPDR ETF (NYSEMKT:XLP) fell 0.6%.

Top 5 Warren Buffett Stocks For 2019: Lawson Products Inc.(LAWS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Lawson Products (NASDAQ:LAWS) is scheduled to announce its earnings results on Thursday, April 19th. Analysts expect the company to announce earnings of $0.16 per share for the quarter.

Top 5 Warren Buffett Stocks For 2019: Guggenheim S&P Global Water ETF (CGW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Jane Street Group LLC bought a new stake in shares of Invesco S&P Global Water Index ETF (NYSEARCA:CGW) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 209,583 shares of the company’s stock, valued at approximately $7,019,000.

Top 5 Warren Buffett Stocks For 2019: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By Keith Speights]

    Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) were trading 14% higher as of 11 a.m. EDT on Friday. The nice jump for the biotech stock came after Galapagos N.V. (NASDAQ:GLPG) announced disappointing results Thursday evening from a phase 2 clinical study evaluating C2 corrector GLPG2737 in treating cystic fibrosis (CF).

  • [By Cory Renauer]

    Galapagos NV (NASDAQ:GLPG) fell out of favor with a lot of investors after AbbVie (NYSE:ABBV) walked away from an important collaboration three years ago. Now that it looks like the discarded candidate could climb to the top of its class, though; the stock is more popular than ever.

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD) delivered some good news for its investors on Tuesday. The big biotech, along with its smaller partner, Galapagos (NASDAQ:GLPG), announced positive results from a phase 3 clinical study evaluating filgotinib in treating rheumatoid arthritis. Gilead’s share price got a nice bump from the news, while Galapagos stock skyrocketed.

Leave a Reply

Your email address will not be published. Required fields are marked *